147 related articles for article (PubMed ID: 32260240)
1. A Self-Calibrating IoT Portable Electrochemical Immunosensor for Serum Human Epididymis Protein 4 as a Tumor Biomarker for Ovarian Cancer.
Bianchi V; Mattarozzi M; Giannetto M; Boni A; De Munari I; Careri M
Sensors (Basel); 2020 Apr; 20(7):. PubMed ID: 32260240
[TBL] [Abstract][Full Text] [Related]
2. Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum.
Mattarozzi M; Giannetto M; Careri M
Talanta; 2020 Sep; 217():120991. PubMed ID: 32498877
[TBL] [Abstract][Full Text] [Related]
3. An ultrasensitive ratiometric electrochemiluminescence immunosensor combining photothermal amplification for ovarian cancer marker detection.
Fang D; Zhang S; Dai H; Lin Y
Biosens Bioelectron; 2019 Dec; 146():111768. PubMed ID: 31606687
[TBL] [Abstract][Full Text] [Related]
4. Electrochemical quantum dots-based magneto-immunoassay for detection of HE4 protein on metal film-modified screen-printed carbon electrodes.
Cadkova M; Kovarova A; Dvorakova V; Metelka R; Bilkova Z; Korecka L
Talanta; 2018 May; 182():111-115. PubMed ID: 29501129
[TBL] [Abstract][Full Text] [Related]
5. Coupling metal-organic framework nanosphere and nanobody for boosted photoelectrochemical immunoassay of Human Epididymis Protein 4.
Chen K; Xue J; Zhou Q; Zhang Y; Zhang M; Zhang Y; Zhang H; Shen Y
Anal Chim Acta; 2020 Apr; 1107():145-154. PubMed ID: 32200889
[TBL] [Abstract][Full Text] [Related]
6. Detection of serum human epididymis secretory protein 4 in patients with ovarian cancer using a label-free biosensor based on localized surface plasmon resonance.
Yuan J; Duan R; Yang H; Luo X; Xi M
Int J Nanomedicine; 2012; 7():2921-8. PubMed ID: 22745553
[TBL] [Abstract][Full Text] [Related]
7. Neutral Charged Immunosensor Platform for Protein-based Biomarker Analysis with Enhanced Sensitivity.
Dai Y; Chiu LY; Chen Y; Qin S; Wu X; Liu CC
ACS Sens; 2019 Jan; 4(1):161-169. PubMed ID: 30582808
[TBL] [Abstract][Full Text] [Related]
8. Clinical Usefulness of Cancer Antigen (CA) 125, Human Epididymis 4, and CA72-4 Levels and Risk of Ovarian Malignancy Algorithm Values for Diagnosing Ovarian Tumors in Korean Patients With and Without Endometriosis.
Shin KH; Kim HH; Kwon BS; Suh DS; Joo JK; Kim KH
Ann Lab Med; 2020 Jan; 40(1):40-47. PubMed ID: 31432638
[TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive immunoassay of carcinoma antigen 125 in untreated human plasma samples using gold nanoparticles with flower like morphology: A new platform in early stage diagnosis of ovarian cancer and efficient management.
Hasanzadeh M; Sahmani R; Solhi E; Mokhtarzadeh A; Shadjou N; Mahboob S
Int J Biol Macromol; 2018 Nov; 119():913-925. PubMed ID: 30081127
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
Ahmed AA; Abdou AM
Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303
[TBL] [Abstract][Full Text] [Related]
11. Making new biomarkers a reality: the case of serum human epididymis protein 4.
Ferraro S; Panteghini M
Clin Chem Lab Med; 2019 Aug; 57(9):1284-1294. PubMed ID: 30511925
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
Dewan R; Dewan A; Jindal M; Bhardawaj M
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480
[TBL] [Abstract][Full Text] [Related]
13. An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma.
Szymanska B; Lukaszewski Z; Zelazowska-Rutkowska B; Hermanowicz-Szamatowicz K; Gorodkiewicz E
Sensors (Basel); 2021 May; 21(10):. PubMed ID: 34065481
[TBL] [Abstract][Full Text] [Related]
14. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
[TBL] [Abstract][Full Text] [Related]
15. The use of aggregation-induced emission probe doped silica nanoparticles for the immunoassay of human epididymis protein 4.
Meng L; Nawaz MAH; Huang X; Ma Y; Li Y; Zhou H; Yu C
Analyst; 2019 Oct; 144(20):6136-6142. PubMed ID: 31536063
[TBL] [Abstract][Full Text] [Related]
16. The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.
Han KH; Park NH; Kim JJ; Kim S; Kim HS; Lee M; Song YS
J Gynecol Oncol; 2019 Nov; 30(6):e83. PubMed ID: 31576682
[TBL] [Abstract][Full Text] [Related]
17. Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management.
Jafari M; Hasanzadeh M; Solhi E; Hassanpour S; Shadjou N; Mokhtarzadeh A; Jouyban A; Mahboob S
Int J Biol Macromol; 2019 Apr; 126():1255-1265. PubMed ID: 30615961
[TBL] [Abstract][Full Text] [Related]
18. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
Zhang M; Zhao B; Xie J; Liang Y; Yang Z
Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
[TBL] [Abstract][Full Text] [Related]
19. HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma.
Langmár Z; Németh M; Vleskó G; Király M; Hornyák L; Bösze P
Eur J Gynaecol Oncol; 2011; 32(6):605-10. PubMed ID: 22335019
[TBL] [Abstract][Full Text] [Related]
20. Electrochemical label-free immunoassay of HE4 using 3D PtNi nanocubes assemblies as biosensing interfaces.
Chen DN; Jiang LY; Zhang JX; Tang C; Wang AJ; Feng JJ
Mikrochim Acta; 2022 Nov; 189(12):455. PubMed ID: 36416993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
